SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-15-004009
Filing Date
2015-05-19
Accepted
2015-05-19 16:58:10
Documents
2
Period of Report
2015-05-15
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT f8k051515_yewbiopharm.htm 8-K 22215
2 PROMISSORY NOTE IN THE AMOUNT OF $648,000 DATED MAY 15, 2015 IN FAVOR OF MS. QI. f8k051515ex10i_yewbiopharm.htm EX-10.1 29492
  Complete submission text file 0001213900-15-004009.txt   52938
Mailing Address 294 POWERBILT AVENUE LAS VEGAS NV 89148
Business Address 294 POWERBILT AVENUE LAS VEGAS NV 89148 86-0451-82292379
Yew Bio-Pharm Group, Inc. (Filer) CIK: 0001548240 (see all company filings)

IRS No.: 261579105 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-54701 | Film No.: 15877172
SIC: 0100 Agricultural Production-Crops